Remove Communication Remove Insurance Coverage and Processing Remove Presentation
article thumbnail

NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the IRA ICR Forms

Putting Patients First Blog

Other members include health-related associations and nonprofit organizations including the provider, research, and family caregiver communities; and businesses and organizations representing biopharmaceuticals, devices, diagnostics, generics, and payers.

article thumbnail

NHC’s comments in response to the 2025 Notice of Benefit and Payment Parameters (NBPP)

Putting Patients First Blog

Making available more specific information about total costs and coverage will ensure that all consumers have comprehensive information to help them make smart health care decisions. These resources should aim to clarify insurance terms and concepts, aiding consumers in navigating the complexities of selecting a health plan.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Release of International Book: “DTx An Opportunity for Italy and Beyond”

pharmaphorum

Contact: Antonietta Pannella, Marketing & Communications Director, Healthware Group. “In some countries, such as Germany, France, and the United Kingdom, certain Digital Therapeutics are readily reimbursed and marketed. .

article thumbnail

MTHFR, Hashimoto’s and Nutrients

The Thyroid Pharmacist

In fact, it’s present in up to 55 percent of the European population, is naturally occurring, and often has no negative health consequences – unless expressed. [1] Unfortunately, synthetic folic acid can be highly problematic for individuals with the MTHFR gene variation, as they may have a difficult time processing this form of folate.

article thumbnail

Clinical trials for rare diseases

European Pharmaceutical Review

Measuring treatment effect in rare disease populations presents many methodological challenges due to small sample sizes and heterogeneity of the study population. When Aidan’s insurance company denied coverage for EXONDYS, the data she captured overturned the denial in 24 hours without engaging in the appeal process.

article thumbnail

ProxsysRx’s Meds To Beds Program Makes Immediate Impact Upon Launch At TMH

Proxsys Rx

Even with her insurance coverage, the co-pay was beyond her means. If it had been a large chain pharmacy, she would have essentially been presented with the option of paying a bill she couldn’t afford — or doing without. Our pharmacists were only too happy to help.

article thumbnail

NHC Comments on Medicare Prescription Payment Plan

Putting Patients First Blog

The NHC supports the development and use of processes and tools that enhance beneficiary experience, making interactions with the MPPP smoother and more intuitive for all beneficiaries. It is vital that communication, both for beneficiaries and for health care providers and pharmacists, adhere to these principles.